We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Needle Fasciotomy Recommended for Treating Viking Disease

By HospiMedica International staff writers
Posted on 26 Jun 2018
A new study shows that needle release is just as effective as pharmaceutical treatment for treating Dupuytren's contracture, a pathological collagen disease that causes crooked fingers.

Researchers at the Sahlgrenska Academy (SA; Göteborg, Sweden) conducted a randomized, single-blinded controlled study that enrolled 156 patients with a Dupuytren contracture of at least 20° in the metacarpophalangeal (MCP) joint in a single finger. More...
The patients were randomized to either percutaneous needle fasciotomy (PNF), or to treatment with injectable Clostridium Histolyticum collagenase (CCH). A single surgeon administered all treatments, and all the patients were seen after one week and blinded to further follow-up.

In addition to the procedure itself, 39 of the patients were examined by ultrasound both before and after treatment in order to compare the morphological appearance of the cord rupture. The patients were assessed after six months, one year, and two years by a single physiotherapist who was blinded to the treatment each patient had received. Outcome measures included measurements (joint motion, recurrence, or prevalence of a Dupuytren cord), and patient reported outcome measures.

The results revealed that patients treated by CCH had significantly more pain and larger skin ruptures than the patients treated by PNF, but there were no other significant outcome differences between the two methods one year after treatment. After two years, 76% of patients treated by CCH and 79% of those treated by PNF still had a straight MCP joint in the treated finger; in over 50% of the patients, no cords were detectable after two years. The study was presented as a doctoral thesis on May 10, 2018.

“In my opinion, there has been excessive faith in the ability of this drug [CCH] to break down the cord better than surgery, while in many places alternative solutions have been forgotten or never even considered,” said lead author and dissertation presenter Joakim Stromberg, MD, PhD. “The needle release is not at all as troublesome for patients. This extremely simple method does not produce as much pain afterwards, nor does it require any specific rehabilitation.”

Dupuytren's contracture, often referred to as "Viking disease," is a common ailment that affects about 10% of men and two percent of women in the Nordic countries. In this condition, a cord consisting of pathological connective tissue forms on the palmar side of the finger, which over time can prevent the finger from being straightened. The pinky and ring fingers are most commonly affected, often in both hands. The disease is most common among individuals older than 60, and has also been linked to factors such as heredity and diabetes. It often recurs and needs to be treated again.

Related Links:
Sahlgrenska Academy


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Multi-Chamber Washer-Disinfector
WD 390
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.